Wednesday, February 08, 2012 9:44 AM
ALung Gets $10M in Series B
New funding helps company further prepare to launch Hemolung, its artificial lung, in Germany this year.
Hemolung ALung Technologies has closed a $10 million Series B financing round as it prepares to launch its artificial lung in Germany this year. Participants in the round included existing shareholders, co-investors of Eagle Ventures and Birchmere Ventures. The Pittsburgh-based company hopes to eventually sell its Hemolung , which helps patients with acute respiratory failure, in the U.S., but it will need at least $25 million more before it can do so, explaine more...
|
Please log in or become a member...
To continue reading this content you must either log in become a member. If you are already a member, please log in using the form below. If you are not already a member, we invite you to join our online community. Membership is free of charge to personnel working in industry, academia, and government.
To join please click on the "Become a Member" link at the top of the page (joining takes around 1 minute and you only need to register once).
Membership benefits include free access to:
-
Industry news, feature articles, podcasts, videos and blogs
-
Weekly eNewsletter subscription
-
Resource Center including downloadable brochures, white papers, reports & media files
-
Industry events calendar
Thank you!
|
Be the first to leave a comment.
Post your comments about this article or questions for the author here